Home NeoLight

NeoLight

Interim Data Shows NeoLight’s Skylife™ Phototherapy discharges Jaundiced infants faster than Standard-of-Care

NeoLight, an empathy-driven medical device company that designs, engineers, and manufactures technologies to treat infants with life-threatening medical conditions, announces today interim data from an ongoing clinical study on the efficacy of NeoLight's Skylife™, a neonatal phototherapy device...

Young Entrepreneurs Receive FDA Clearance for Medical Device Poised to Disrupt Newborn Care Market

NeoLight announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market the Skylife™ portable phototherapy system. The Skylife device delivers a narrow band of high-intensity blue light via blue light emitting diodes to provide treatment for neonatal unconjugated hyperbilirubinemia (jaundice).